183 related articles for article (PubMed ID: 3874784)
1. Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD).
Bartmann K; Fooke-Achterrath M; Koch G; Nagy I; Schütz I; Weis E; Zierski M
Eur J Respir Dis; 1985 Apr; 66(4):284-96. PubMed ID: 3874784
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals.
Dahl M; Nordestgaard BG; Lange P; Vestbo J; Tybjaerg-Hansen A
Clin Chem; 2001 Jan; 47(1):56-62. PubMed ID: 11148177
[TBL] [Abstract][Full Text] [Related]
3. Alpha 1-antitrypsin Pi-types in 965 COPD patients.
Lieberman J; Winter B; Sastre A
Chest; 1986 Mar; 89(3):370-3. PubMed ID: 3485034
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group.
Turino GM; Barker AF; Brantly ML; Cohen AB; Connelly RP; Crystal RG; Eden E; Schluchter MD; Stoller JK
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1718-25. PubMed ID: 8970361
[TBL] [Abstract][Full Text] [Related]
6. [Phenotype Pi and alpha 1 antitrypsin deficiency in types A and B chronic obstructive bronchopneumopathies].
Dyan A; Martin JP; Saint-Paul M; Baud F; Bignon J
Pathol Biol (Paris); 1975 Sep; 23(7):525-33. PubMed ID: 1101155
[TBL] [Abstract][Full Text] [Related]
7. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
[TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
9. Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of Oslo.
Gulsvik A; Fagerhol MK
Scand J Respir Dis; 1979 Oct; 60(5):267-74. PubMed ID: 316573
[TBL] [Abstract][Full Text] [Related]
10. Pi-Z phenotypes in a pulmonary clinic. Their prevalence and physiologic state.
Gerblich AA; Kleinerman J; Rynbrandt DJ; Chester EH; Ihrig J
Am J Clin Pathol; 1978 May; 69(5):509-13. PubMed ID: 306745
[TBL] [Abstract][Full Text] [Related]
11. Chronic obstructive pulmonary disease and alpha-1-antitrypsin (Pi) variation: a family study.
Benjamin JJ; Cohen BH; Ball WC; Levy DA; Menkes HA; Kreiss P
Birth Defects Orig Artic Ser; 1974; 10(4):212-6. PubMed ID: 4549777
[TBL] [Abstract][Full Text] [Related]
12. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals.
Lara B; Miravitlles M
COPD; 2015 May; 12 Suppl 1():27-31. PubMed ID: 25938288
[TBL] [Abstract][Full Text] [Related]
13. Interactions of neutrophil elastase, serum trypsin inhibitory activity, and smoking history as risk factors for chronic obstructive pulmonary disease in patients with MM, MZ, and ZZ phenotypes for alpha-antitrypsin.
Galdston M; Melnick EL; Goldring RM; Levytska V; Curasi CA; Davis AL
Am Rev Respir Dis; 1977 Nov; 116(5):837-46. PubMed ID: 303486
[No Abstract] [Full Text] [Related]
14. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
[TBL] [Abstract][Full Text] [Related]
15. [Obstructive pulmonary syndromes in children with alpha 1 antitrypsin deficiency. 3 cases].
Gerbeaux J; Grimfeld A; Gaultier C; Baculard A; Mensch B; Tournier G
Nouv Presse Med; 1975 Dec; 4(43):3045-50. PubMed ID: 1083504
[TBL] [Abstract][Full Text] [Related]
16. α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.
Sørheim IC; Bakke P; Gulsvik A; Pillai SG; Johannessen A; Gaarder PI; Campbell EJ; Agustí A; Calverley PM; Donner CF; Make BJ; Rennard SI; Vestbo J; Wouters EF; Paré PD; Levy RD; Coxson HO; Lomas DA; Hersh CP; Silverman EK
Chest; 2010 Nov; 138(5):1125-32. PubMed ID: 20595457
[TBL] [Abstract][Full Text] [Related]
17. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease.
Ghosh AJ; Hobbs BD; Moll M; Saferali A; Boueiz A; Yun JH; Sciurba F; Barwick L; Limper AH; Flaherty K; Criner G; Brown KK; Wise R; Martinez FJ; Lomas D; Castaldi PJ; Carey VJ; DeMeo DL; Cho MH; Silverman EK; Hersh CP;
Am J Respir Crit Care Med; 2022 Feb; 205(3):313-323. PubMed ID: 34762809
[No Abstract] [Full Text] [Related]
19. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
Cox DW; Hoeppner VH; Levison H
Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
[TBL] [Abstract][Full Text] [Related]
20. Relation of alpha-1-antitrypsin phenotype to the performance of pulmonary function tests and to the prevalence of respiratory illness in a working population.
Cole RB; Nevin NC; Blundell G; Merrett JD; McDonald JR; Johnston WP
Thorax; 1976 Apr; 31(2):149-57. PubMed ID: 781898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
